PF-04554878

· Verastem, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-04554878, covering 2017-01-25 to 2017-01-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies [Phase 1]